{"id":"W2951051106","doi":"10.1097/01.hs9.0000559844.15284.b3","title":"PF408 DASFREE 2‐YEAR UPDATE: DASATINIB DISCONTINUATION IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP) AND DEEP MOLECULAR RESPONSE (DMR)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Clinical endpoint; Oncology; Myeloid leukemia; Imatinib; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003998732,0.0004867145,0.0007114866,0.0002045409,0.00004906344,0.00004240977,0.0001827673,0.0002587706,0.001055877],"category_scores_gemma":[0.0001308382,0.0004234954,0.00007804822,0.0005645059,0.0001256601,0.0003347799,0.0001307015,0.0005271434,0.0002895137],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01108444,"about_ca_system_score_gemma":0.002257864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003786896,"about_ca_topic_score_gemma":0.001901495,"domain_scores_codex":[0.9969196,0.0002169718,0.0006324979,0.00089906,0.0006007999,0.0007310296],"domain_scores_gemma":[0.9983943,0.0001189456,0.0002315625,0.0009442504,0.00008570366,0.0002252514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02965015,0.002416756,0.8050886,0.001431083,0.0005340925,0.001492948,0.00278055,0.002382445,0.05211382,0.000539662,0.0006821154,0.1008877],"study_design_scores_gemma":[0.2389255,0.01297415,0.7031078,0.003464546,0.0003466915,0.000111403,0.000758032,0.01253869,0.01977627,0.0001227046,0.006255785,0.001618333],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942794,0.002048526,0.00006783259,0.0001865698,0.00008198246,0.002197171,0.00002120783,0.00007148072,0.001045864],"genre_scores_gemma":[0.9973669,0.0001602831,0.0008114091,0.0001377936,0.00007142683,0.0001427094,0.000325706,0.0001094762,0.000874272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2092754,"threshold_uncertainty_score":0.9998573,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005851570532110407,"score_gpt":0.2490257165313177,"score_spread":0.2431741459992073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}